Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells
- PMID: 4052991
- DOI: 10.1016/0304-3835(85)90077-1
Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells
Abstract
The interaction between adriamycin influx, efflux and cytotoxicity has been studied in Chinese hamster ovary (CHO) cells. The rate of adriamycin uptake showed no evidence of saturation with increasing concentration suggesting that uptake occurred by passive diffusion. Plateau levels of adriamycin were reached within 20 min and more than 60% of this was firmly bound to the nucleus and did not efflux. Cytotoxicity studies did not correlate with uptake studies in that cell killing was an exponential function of drug exposure time well beyond the point at which intracellular concentrations had reached a maximum. This suggests that bound adriamycin is not primarily responsible for cytotoxicity.
Similar articles
-
Modulation of adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A.Cancer Chemother Pharmacol. 2000;45(3):219-30. doi: 10.1007/s002800050033. Cancer Chemother Pharmacol. 2000. PMID: 10663640
-
Hyperthermia, adriamycin transport, and cytotoxicity in drug-sensitive and -resistant Chinese hamster ovary cells.Cancer Res. 1986 Nov;46(11):5477-81. Cancer Res. 1986. PMID: 3756895
-
A lack of adriamycin (ADR) resistance in Chinese hamster ovary (CHO) cells overexpressing P-glycoprotein (Pgp) following in vitro exposure to fractionated X-irradiation.Biochem Soc Trans. 1991 Apr;19(2):125S. doi: 10.1042/bst019125s. Biochem Soc Trans. 1991. PMID: 1679723 No abstract available.
-
Reduction by caffeine of adriamycin-induced cell killing and DNA damage in Chinese hamster cells: correlation with modulation in intracellular adriamycin content.Cancer Res. 1987 May 1;47(9):2224-9. Cancer Res. 1987. PMID: 3552213
-
Cell surface actions of adriamycin.Pharmacol Ther. 1991;49(3):293-309. doi: 10.1016/0163-7258(91)90060-y. Pharmacol Ther. 1991. PMID: 2052627 Review.
Cited by
-
Doxorubicin cellular pharmacokinetics and DNA breakage in a multi-drug resistant B16 melanoma cell line.Br J Cancer. 1988 Feb;57(2):142-6. doi: 10.1038/bjc.1988.30. Br J Cancer. 1988. PMID: 3358904 Free PMC article.
-
Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake.PLoS One. 2020 Oct 15;15(10):e0240454. doi: 10.1371/journal.pone.0240454. eCollection 2020. PLoS One. 2020. PMID: 33057448 Free PMC article.
-
Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin.Cancer Chemother Pharmacol. 1988;21(3):251-4. doi: 10.1007/BF00262780. Cancer Chemother Pharmacol. 1988. PMID: 3359560
-
The effect of hyperthermia in combination with melphalan on drug-sensitive and drug-resistant CHO cells in vitro.Br J Cancer. 1990 Aug;62(2):183-8. doi: 10.1038/bjc.1990.257. Br J Cancer. 1990. PMID: 1974814 Free PMC article.
-
Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.Neoplasia. 2005 Jul;7(7):705-13. doi: 10.1593/neo.05118. Neoplasia. 2005. PMID: 16026650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources